According to our (Global Info Research) latest study, the global Colorectal Cancer Molecular Diagnostics market size was valued at US$ 704 million in 2023 and is forecast to a readjusted size of USD 1727 million by 2030 with a CAGR of 13.8% during review period.
Global core colorectal cancer molecular diagnostics players include Roche Diagnostics, Abbott and Thermo Fisher etc. The top 3 companies hold a share about 45%. Middle East and Africa is the largest market with a share about 43%, followed by Asia-Pacific and Europe.
In terms of product, polymerase chain reaction PCR is the largest segment with a share about 50%. And in terms of applications, the largest application is third-party testing agency with a share about 48%.
This report is a detailed and comprehensive analysis for global Colorectal Cancer Molecular Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Colorectal Cancer Molecular Diagnostics market size and forecasts, in consumption value ($ Million), 2019-2030
Global Colorectal Cancer Molecular Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Colorectal Cancer Molecular Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Colorectal Cancer Molecular Diagnostics market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Colorectal Cancer Molecular Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Colorectal Cancer Molecular Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent, Daangene, Amoydx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Colorectal Cancer Molecular Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Colorectal Cancer Molecular Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Market segment by Application
Hospital
Third-Party Testing Agency
Others
Market segment by players, this report covers
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Colorectal Cancer Molecular Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Colorectal Cancer Molecular Diagnostics, with revenue, gross margin, and global market share of Colorectal Cancer Molecular Diagnostics from 2019 to 2024.
Chapter 3, the Colorectal Cancer Molecular Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Colorectal Cancer Molecular Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Colorectal Cancer Molecular Diagnostics.
Chapter 13, to describe Colorectal Cancer Molecular Diagnostics research findings and conclusion.
Summary:
Get latest Market Research Reports on Colorectal Cancer Molecular Diagnostics. Industry analysis & Market Report on Colorectal Cancer Molecular Diagnostics is a syndicated market report, published as Global Colorectal Cancer Molecular Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Colorectal Cancer Molecular Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.